PXS is one of those stocks that is staying afloat because it grinds its way through..... little income, little income there, cover the research of new products, partner up with others and do what needs to be done. Its a bio-tech equivalent of an oil stock with new fields, but less risk. Frankly the upside potential is worth the holding cost.
- Forums
- ASX - By Stock
- SNT
- Ann: PXS Doses First Patient in Phase 2 Bone Marrow Cancer Trial
Ann: PXS Doses First Patient in Phase 2 Bone Marrow Cancer Trial, page-9
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.82M |
Open | High | Low | Value | Volume |
3.0¢ | 3.3¢ | 3.0¢ | $196.5K | 6.494M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 224999 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.2¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 224999 | 0.030 |
2 | 80000 | 0.029 |
4 | 1130000 | 0.028 |
4 | 1230000 | 0.027 |
4 | 618461 | 0.026 |
Price($) | Vol. | No. |
---|---|---|
0.032 | 50000 | 1 |
0.033 | 502015 | 4 |
0.034 | 421181 | 4 |
0.035 | 1000000 | 1 |
0.036 | 132000 | 2 |
Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online